A Phase 2 Trial to Investigate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 SC in Adult Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (ADHERE)
Clinical Trial Grant
Administered By
Neurology, Neuromuscular Disease
Awarded By
Argenex BVBA
Start Date
July 27, 2020
End Date
September 6, 2022
Administered By
Neurology, Neuromuscular Disease
Awarded By
Argenex BVBA
Start Date
July 27, 2020
End Date
September 6, 2022